Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery Post author: Post published:March 20, 2024 Post category:uncategorized Post Content You Might Also Like Study reveals £4bn savings potential from dementia risk reduction interventions July 31, 2024 Calorie labels on menus may benefit people with binge eating disorders April 15, 2026 Newborns and Alzheimer’s patients have elevated blood levels of phosphorylated tau June 24, 2025